Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 5 SUPPL., 2001, Pages 818-823

  Dahl, Morten ^a   Nordestgaard, Børge G ^a,c   Lange, Peter ^b,c   Tybjaerg Hansen, Anne ^a,c,d  

^a Mental Health Services CPH   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Asthma; Cystic fibrosis heterozygosity; Genetic screening; Pulmonary function; F508 mutation

Indexed keywords

PHENYLALANINE;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; CYSTIC FIBROSIS; DENMARK; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENE DELETION; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035023369     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.114117     Document Type: Article

References (34)

1. Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997;349:1436-42.
2. Crater SE, Platts-Mills TA. Searching for the cause of the increase in asthma. Curr Opin Pediatr 1998;10:594-9.
3. Woolcock AJ. Asthma. In: Nadel JA, Murray JF, editors. Textbook of Respiratory Medicine. 2nd Ed. Philadelphia: WB Saunders; 1994. p. 1288-330.
4. Dahl M, Tybjærg-Hansen A, Lange P, Nordestgaard BG. δF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998;351:1911-3.
5. Swift M, Su Y [reply by Dahl M, Tybjorg-Hansen A, Lange P, Nordestgaard BG]. δF508 heterozygosity and asthma [correspondence]. Lancet 1998;352:984-7.
6. Welsh M, Tsui L-P, Boat T, Beaudet A. Cystic fibrosis. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th Ed. New York: McGraw-Hill; 1995. p. 3799-876.
7. Davis P, Drumm M, Konstan M. Cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-56.
8. Cropp GJ. Effectiveness of bronchodilators in cystic fibrosis. Am J Med 1996;100(1A):19S-29S.
9. Counahan R, Mearns MB. Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis. Arch Dis Child 1995;50:477-81.
10. Davis P. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis 1984;129:911-4.
11. Davis P, Vargo K. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax 1987;42:120-5.
12. Jensen G. Epidemiology of chest pain and angina pectoris. Acta Med Scand Suppl 1984;602:1-120.
13. Appleyard M. The Copenhagen City Heart Study: Østerbroundersøgelsen: A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-1983). Scand J Soc Med 1989;170(Suppl 41):1-160.
14. Burrows B. Airways obstructive diseases: Pathogenetic mechanisms and natural histories of the disorders. Med Clin North Am 1990;74:547-59.
15. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994;150:629-34.
16. Boulet L-P, Turcotte H, Brochu A. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest 1994; 105:1024-31.
17. Gasparini P, Bonizzato A, Dognini M, Pignatti PF. Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: Application to the study of some common cystic fibrosis mutations. Mol Cell Probes 1992;6:1-7.
18. EStivill E, Bancells C, Ramos C, the Biomed CF Mutation Analysis Consortium. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. Hum Mutat 1997;10:135-54.
19. SPSS Base 7.0 for Windows User's Guide. Chicago (IL): SPSS Inc; 1996.
20. Orzalesi M, Kohner D, Cook C, Shwachmann H. Anamnesis, sweat electrolyte and pulmonary function studies in parents of patients with cystic fibrosis of the pancreas. Acta Paediatr Scand 1963;52:267-76.
21. Hallet W, Knudson A, Massey F. Absence of detrimental effect of the carrier state for the cystic fibrosis gene. Am Rev Respir Dis 1965;90:714-24.
22. Byard P, Davis P. Pulmonary function in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis 1988;138:312-6.
23. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991; 303:671-5.
24. Vollmer WM, Osborne M, Buist AS. 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med 1998;157:1079-84.
25. Griesenbach U, Geddes DM, Alton EWFW. The pathogenetic consequences of a single mutated CFTR gene. Thorax 1999;54(Suppl 2):S19-23.
26. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR δF508 mutation: A heterozygote advantage in cystic fibrosis. Nat Med 1995;1:703-5.
27. Warner JO, Kilburn SA. Cystic fibrosis and allergy. Pediatr Allergy Immunol 1996;7(Suppl 9):67-9.
28. Becker JW, Burke W, McDonald G, Greenberger PA, Henderson WR, Aitken ML. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 1996;109:1536-40.
29. Wills R, Henry RL, Francis JL. Antibiotic hypersensitivity reactions in cystic fibrosis. J Paediatr Child Health 1998;34:325-9.
30. Warner JO, Norman AP, Soothill JF. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet 1976;1:990-1.
31. Miller PW, Hamosh A, Macek M Jr, Greenberger PA, MacLean J, Walden SM, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51.
32. Lowenfels AB, Maisonneuve P, Palys B, Schöni MH, Redemann B [correspondence]. Lancet 1998;352:985.
33. Lange P, Groth S, Nyboe J, Appleyard M, Mortensen J, Jensen G, et al. Chronic obstructive lung disease in Copenhagen: Cross-sectional epidemiological aspects. J Intern Med 1989;226:25-32.
34. Kauppi P, Laitinen LA, Laitinen H, Kere J, Laitinen T. Verification of self-reported asthma and allergy in subjects and their family members volunteering for gene mapping studies. Respir Med 1998;92:1281-8.